In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 5, 2015, Pages 862-890

  Helms, Hans C ^a   Abbott, N Joan ^b   Burek, Malgorzata ^c   Cecchelli, Romeo ^d   Couraud, Pierre Olivier ^e   Deli, Maria A ^f   Förster, Carola ^c   Galla, Hans J ^g   Romero, Ignacio A ^h   Shusta, Eric V ⁱ   Stebbins, Matthew J ⁱ   Vandenhaute, Elodie ^d   Weksler, Babette ^j   Brodin, Birger ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITÉ D'ARTOIS   (France)

^e INSTITUT COCHIN   (France)

^f INSTITUTE OF BIOCHEMISTRY   (Hungary)

^g UNIVERSITY OF MÜNSTER   (Germany)

^h OPEN UNIVERSITY   (United Kingdom)

ⁱ University of Wisconsin Madison   (United States)

^j WEILL CORNELL MEDICAL COLLEGE   (United States)

more..

Author keywords

astrocytes; Blood brain barrier; endothelium; pericytes; stem cells

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL CELL CULTURE; ASTROCYTE; BLOOD BRAIN BARRIER; BOVINE MODEL; CELL CULTURE; CELL IMMORTALIZATION; COCULTURE; ENDOTHELIUM CELL; HUMAN; IN VITRO STUDY; MOUSE MODEL; NONHUMAN; PORCINE MODEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RAT MODEL; REVIEW; STEM CELL; BIOLOGICAL MODEL; BRAIN; CYTOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

BLOOD-BRAIN BARRIER; BRAIN; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GUIDELINES AS TOPIC; HUMANS; MODELS, BIOLOGICAL;

EID: 84964963511     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16630991     Document Type: Review

References (299)

1. Mathiisen TM, Lehre KP, Danbolt NC, et al. The perivas-cular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 2010; 58: 1094-1103.
2. Abbott NJ. Anatomy and physiology of the blood-brain barriers. In: Hammarlund-Udenaes M, de Lange ECM and Thorne RG (eds) Drug delivery to the brain. New York, NY: Springer, 2014, pp.3-21.
3. Abbott NJ, Ronnback L and Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7: 41-53.
4. Bowman PD, Ennis SR, Rarey KE, et al. Brain microves-sel endothelial cells in tissue culture: a model for study of blood-brain barrier permeability. Ann Neurol 1983; 14: 396-402.
5. Rubin LL, Hall DE, Porter S, et al. A cell culture model of the blood-brain barrier. J Cell Biol 1991; 115: 1725-1735.
6. Jaffe EA, Hoyer LW and Nachman RL. Synthesis of anti-hemophilic factor antigen by cultured human endothelial cells. J Clin Invest 1973; 52: 2757-2764.
7. Dorovini-Zis K and Huynh HK. Ultrastructural localization of factor VIII-related antigen in cultured human brain microvessel endothelial cells. J Histochem Cytochem 1992; 40: 689-696.
8. Muller AM, Hermanns MI, Skrzynski C, et al. Expression of the endothelial markers PECAM-1, vWf, and CD34 in vivo and in vitro. Exp Mol Pathol 2002; 72: 221-229.
9. Nitta T, Hata M, Gotoh S, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003; 161: 653-660.
10. Furuse M, Hirase T, Itoh M, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993; 123: 1777-1788.
11. Morita K, Sasaki H, Furuse M, et al. Endothelial clau-din: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 1999; 147: 185-194.
12. Crone C and Olesen SP. Electrical resistance of brain microvascular endothelium. Brain Res 1982; 241: 49-55.
13. Butt AM, Jones HC and Abbott NJ. Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J Physiol 1990; 429: 47-62.
14. Brightman MW and Reese TS. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol 1969; 40: 648-677.
15. Ohno K, Pettigrew KD and Rapoport SI. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol 1978; 235: H299-H307.
16. Smith QR and Rapoport SI. Cerebrovascular permeability coefficients to sodium, potassium, and chloride. J Neurochem 1986; 46: 1732-1742.
17. Schinkel AH, Smit JJ, van Tellingen O, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491-502.
18. Cordon-Cardo C, O'Brien JP, Casals D, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothe-lial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989; 86: 695-698.
19. Eisenblatter T and Galla HJ. A new multidrug resistance protein at the blood-brain barrier. Biochem Biophys Res Commun 2002; 293: 1273-1278.
20. Cooray HC, Blackmore CG, Maskell L, et al. Localisation of breast cancer resistance protein in micro-vessel endothelium of human brain. Neuroreport 2002; 13: 2059-2063.
21. Zhang W, Mojsilovic-Petrovic J, Andrade MF, et al. The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J 2003; 17: 2085-2087.
22. Maliepaard M, Scheffer GL, Faneyte IF, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 2001; 61: 3458-3464.
23. Leggas M, Adachi M, Scheffer GL, et al. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol 2004; 24: 7612-7621.
24. Miller DS, Nobmann SN, Gutmann H, et al. Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol Pharmacol 2000; 58: 1357-1367.
25. Zhang Y, Schuetz JD, Elmquist WF, et al. Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells. J Pharmacol Exp Ther 2004; 311: 449-455.
26. Crone C. Facilitated transfer of glucose from blood into brain tissue. J Physiol 1965; 181: 103-113.
27. Nualart F, Godoy A and Reinicke K. Expression of the hexose transporters GLUT1 and GLUT2 during the early development of the human brain. Brain Res 1999; 824: 97-104.
28. Zheng PP, Romme E, van der Spek PJ, et al. Glut1/SLC2A1 is crucial for the development of the blood-brain barrier in vivo. Ann Neurol 2010; 68: 835-844.
29. Boado RJ, Li JY, Nagaya M, et al. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci USA 1999; 96: 12079-12084.
30. Oldendorf WH and Szabo J. Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am J Physiol 1976; 230: 94-98.
31. Gerhart DZ, Enerson BE, Zhdankina OY, et al. Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats. Am J Physiol 1997; 273: E207-E213.
32. Kido Y, Tamai I, Okamoto M, et al. Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies. Pharm Res 2000; 17: 55-62.
33. Oldendorf WH. Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am J Physiol 1973; 224: 1450-1453.
34. Jefferies WA, Brandon MR, Hunt SV, et al. Transferrin receptor on endothelium of brain capillaries. Nature 1984; 312: 162-163.
35. Yu YJ, Atwal JK, Zhang Y, et al. Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates. Sci Transl Med 2014; 6: 261ra154.
36. Morris CM, Keith AB, Edwardson JA, et al. Uptake and distribution of iron and transferrin in the adult rat brain. J Neurochem 1992; 59: 300-306.
37. Alvarez JI, Dodelet-Devillers A, Kebir H, et al. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 2011; 334: 1727-1731.
38. Lee SW, Kim WJ, Choi YK, et al. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med 2003; 9: 900-906.
39. Hayashi Y, Nomura M, Yamagishi S, et al. Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astro-cytes. Glia 1997; 19: 13-26.
40. Janzer RC and Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987; 325: 253-257.
41. Armulik A, Genove G, Mae M, et al. Pericytes regulate the blood-brain barrier. Nature 2010; 468: 557-561.
42. Daneman R, Zhou L, Kebede AA, et al. Pericytes are required for blood-brain barrier integrity during embryo-genesis. Nature 2010; 468: 562-566.
43. Daneman R, Zhou L, Agalliu D, et al. The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS One 2010; 5: e13741.
44. Dauchy S, Dutheil F, Weaver RJ, et al. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 2008; 107: 1518-1528.
45. Enerson BE and Drewes LR. The rat blood-brain barrier transcriptome. J Cereb Blood Flow Metab 2006; 26: 959-973.
46. Geier EG, Chen EC, Webb A, et al. Profiling solute carrier transporters in the human blood-brain barrier. Clin Pharmacol Ther 2013; 94: 636-639.
47. Guo S, Zhou Y, Xing C, et al. The vasculome of the mouse brain. PLoS One 2012; 7: e52665.
48. Kubo Y, Ohtsuki S, Uchida Y, et al. Quantitative determination of luminal and abluminal membrane distributions of transporters in porcine brain capillaries by plasma membrane fractionation and quantitative targeted proteomics. J Pharm Sci 2015; 104: 3060-3068.
49. Shawahna R, Uchida Y, Decleves X, et al. Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol Pharm 2011; 8: 1332-1341.
50. Uchida Y, Ohtsuki S, Katsukura Y, et al. Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 2011; 117: 333-345.
51. Zhang Y, Chen K, Sloan SA, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 2014; 34: 11929-11947.
52. Srinivasan B, Kolli AR, Esch MB, et al. TEER measurement techniques for in vitro barrier model systems. J Lab Autom 2015; 20: 107-126.
53. Helms HC, Hersom M, Kuhlmann LB, et al. An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the abc transporters, P-gp, Bcrp and Mrp-1. AAPS J 2014; 16: 1046-1055.
54. Patabendige A, Skinner RA, Morgan L, et al. A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells. Brain Res 2013; 1521: 16-30.
55. Watson PM, Paterson JC, Thom G, et al. Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier. BMC Neurosci 2013; 14: 59.
56. Gaillard PJ and de Boer AG. Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug. Eur J Pharm Sci 2000; 12: 95-102.
57. Lohmann C, Huwel S and Galla HJ. Predicting blood-brain barrier permeability of drugs: evaluation of different in vitro assays. J Drug Target 2002; 10: 263-276.
58. Liu H, Li Y, Lu S, et al. Temporal expression of transporters and receptors in a rat primary co-culture blood-brain barrier model. Xenobiotica 2014; 44: 941-951.
59. Furuse M. Molecular basis of the core structure of tight junctions. Cold Spring Harb Perspect Biol 2010; 2: a002907.
60. Krause G, Winkler L, Mueller SL, et al. Structure and function of claudins. Biochim Biophys Acta 2008; 1778: 631-645.
61. Fukuta M, Okada H, Iinuma S, et al. Insulin fragments as a carrier for peptide delivery across the blood-brain barrier. Pharm Res 1994; 11: 1681-1688.
62. Pardridge WM, Kang YS, Buciak JL, et al. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm Res 1995; 12: 807-816.
63. Dehouck B, Fenart L, Dehouck MP, et al. A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol 1997; 138: 877-889.
64. Bockenhoff A, Cramer S, Wolte P, et al. Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A. J Neurosci 2014; 34: 3122-3129.
65. Visser CC, Voorwinden LH, Crommelin DJ, et al. Characterization and modulation of the transferrin receptor on brain capillary endothelial cells. Pharm Res 2004; 21: 761-769.
66. Tamaru M, Akita H, Fujiwara T, et al. Leptin-derived peptide, a targeting ligand for mouse brain-derived endo-thelial cells via macropinocytosis. Biochem Biophys Res Commun 2010; 394: 587-592.
67. Gaillard PJ, Brink B and de Boer AG. Diphteria toxin receptor-targeted brain drug delivery. Int Cong Ser 2005; 1277: 185-198.
68. Rip J, Chen L, Hartman R, et al. Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats. J Drug Target 2014; 22: 460-467.
69. Georgieva JV, Hoekstra D and Zuhorn IS. Smuggling drugs into the brain: an overview of ligands targeting transcytosis for drug delivery across the blood-brain barrier. Pharmaceutics 2014; 6: 557-583.
70. Niewoehner J, Bohrmann B, Collin L, et al. Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle. Neuron 2014; 81: 49-60.
71. Regina A, Demeule M, Che C, et al. Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2. Br J Pharmacol 2008; 155: 185-197.
72. Thomas FC, Taskar K, Rudraraju V, et al. Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer. Pharm Res 2009; 26: 2486-2494.
73. Che C, Yang G, Thiot C, et al. New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) che-motherapeutics with increased brain penetration. J Med Chem 2010; 53: 2814-2824.
74. Regina A, Demeule M, Tripathy S, et al. ANG4043, a novel brain-penetrant peptide-mAb conjugate, is efficacious against HER2-positive intracranial tumors in mice. Mol Cancer Ther 2015; 14: 129-140.
75. Candela P, Saint-Pol J, Kuntz M, et al. In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain peri-cytes. Brain Res 2015; 1594: 15-26.
76. Gosselet F, Candela P, Sevin E, et al. Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model. Brain Res 2009; 1249: 34-42.
77. Demeule M, Currie JC, Bertrand Y, et al. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem 2008; 106: 1534-1544.
78. Zhao Z, Sagare AP, Ma Q, et al. Central role for PICALM in amyloid-beta blood-brain barrier transcy-tosis and clearance. Nat Neurosci 2015; 18: 978-987.
79. Hartz AM, Miller DS and Bauer B. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Mol Pharmacol 2010; 77: 715-723.
80. Joo F and Karnushina I. A procedure for the isolation of capillaries from rat brain. Cytobios 1973; 8: 41-48.
81. Mrsulja BB, Mrsulja BJ, Fujimoto T, et al. Isolation of brain capillaries: a simplified technique. Brain Res 1976; 110: 361-365.
82. Erdlenbruch B, Alipour M, Fricker G, et al. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries. Br J Pharmacol 2003; 140: 1201-1210.
83. Fricker G, Nobmann S and Miller DS. Permeability of porcine blood brain barrier to somatostatin analogues. Br J Pharmacol 2002; 135: 1308-1314.
84. Hartz AM, Bauer B, Fricker G, et al. Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysac-charide. Mol Pharmacol 2006; 69: 462-470.
85. Bowman PD, Betz AL, Ar D, et al. Primary culture of capillary endothelium from rat brain. In Vitro 1981; 17: 353-362.
86. DeBault LE, Kahn LE, Frommes SP, et al. Cerebral microvessels and derived cells in tissue culture: isolation and preliminary characterization. In Vitro 1979; 15: 473-487.
87. DeBault LE and Cancilla PA. Gamma-glutamyl trans-peptidase in isolated brain endothelial cells: induction by glial cells in vitro. Science 1980; 207: 653-655.
88. Tao-Cheng JH, Nagy Z and Brightman MW. Tight junctions of brain endothelium in vitro are enhanced by astroglia. J Neurosci 1987; 7: 3293-3299.
89. Dehouck MP, Meresse S, Delorme P, et al. An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J Neurochem 1990; 54: 1798-1801.
90. Cecchelli R, Dehouck B, Descamps L, et al. In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev 1999; 36: 165-178.
91. Gaillard PJ, Voorwinden LH, Nielsen JL, et al. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astro-cytes. Eur J Pharm Sci 2001; 12: 215-222.
92. Malina KCK, Cooper I and Teichberg VI. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness. Brain Research 2009; 1284: 12-21.
93. Abbott NJ, Dolman DE, Drndarski S, et al. An improved in vitro blood-brain barrier model: rat brain endothelial cells co-cultured with astrocytes. Methods Mol Biol 2012; 814: 415-430.
94. Boveri M, Berezowski V, Price A, et al. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line. Glia 2005; 51: 187-198.
95. Culot M, Lundquist S, Vanuxeem D, et al. An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening. Toxicol In Vitro 2008; 22: 799-811.
96. Perriere N, Yousif S, Cazaubon S, et al. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters. Brain Res 2007; 1150: 1-13.
97. Nakagawa S, Deli MA, Kawaguchi H, et al. A new blood-brain barrier model using primary rat brain endo-thelial cells, pericytes and astrocytes. Neurochem Int 2009; 54: 253-263.
98. Nakagawa S, Deli MA, Nakao S, et al. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell Mol Neurobiol 2007; 27: 687-694.
99. Dohgu S, Takata F, Yamauchi A, et al. Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production. Brain Res 2005; 1038: 208-215.
100. Hayashi K, Nakao S, Nakaoke R, et al. Effects of hyp-oxia on endothelial/pericytic co-culture model of the blood-brain barrier. Regul Pept 2004; 123: 77-83.
101. Vandenhaute E, Dehouck L, Boucau MC, et al. Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes. Curr Neurovasc Res 2011; 8: 258-269.
102. Wilhelm I, Fazakas C and Krizbai IA. In vitro models of the blood-brain barrier. Acta Neurobiol Exp (Wars) 2011; 71: 113-128.
103. Hatherell K, Couraud PO, Romero IA, et al. Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models. J Neurosci Methods 2011; 199: 223-229.
104. Franke H, Galla HJ and Beuckmann CT. An improved low-permeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res 1999; 818: 65-71.
105. Hoheisel D, Nitz T, Franke H, et al. Hydrocortisone reinforces the blood-brain properties in a serum free cell culture system. Biochem Biophys Res Commun 1998; 247: 312-315.
106. Patabendige A, Skinner RA and Abbott NJ. Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance. Brain Res 2013; 1521: 1-15.
107. Helms HC, Waagepetersen HS, Nielsen CU, et al. Paracellular tightness and claudin-5 expression is increased in the BCEC/astrocyte blood-brain barrier model by increasing media buffer capacity during growth. AAPS J 2010; 12: 759-770.
108. Burek M, Salvador E and Forster CY. Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model. J Vis Exp 2012; 66: e4022.
109. Coisne C, Dehouck L, Faveeuw C, et al. Mouse syn-genic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium. Lab Invest 2005; 85: 734-746.
110. Forster C, Silwedel C, Golenhofen N, et al. Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. J Physiol 2005; 565: 475-486.
111. Bernas MJ, Cardoso FL, Daley SK, et al. Establishment of primary cultures of human brain microvascular endo-thelial cells to provide an in vitro cellular model of the blood-brain barrier. Nat Protoc 2010; 5: 1265-1272.
112. Prat A, Biernacki K, Pouly S, et al. Kinin B1 receptor expression and function on human brain endothelial cells. J Neuropathol Exp Neurol 2000; 59: 896-906.
113. Subileau EA, Rezaie P, Davies HA, et al. Expression of chemokines and their receptors by human brain endothelium: implications for multiple sclerosis. J Neuropathol Exp Neurol 2009; 68: 227-240.
114. Weksler BB, Subileau EA, Perriere N, et al. Blood-brain barrier-specific properties of a human adult brain endo-thelial cell line. FASEB J 2005; 19: 1872-1874.
115. Stins MF, Badger J and Sik Kim K. Bacterial invasion and transcytosis in transfected human brain microvascu-lar endothelial cells. Microb Pathog 2001; 30: 19-28.
116. Boyer-Di Ponio J, El-Ayoubi F, Glacial F, et al. Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes. PLoS One 2014; 9: e84179.
117. Cecchelli R, Aday S, Sevin E, et al. A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells. PLoS One 2014; 9: e99733.
118. Lippmann ES, Azarin SM, Kay JE, et al. Derivation of blood-brain barrier endothelial cells from human pluri-potent stem cells. Nat Biotechnol 2012; 30: 783-791.
119. Stamatovic SM, Keep RF, Kunkel SL, et al. Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J Cell Sci 2003; 116: 4615-4628.
120. Weidenfeller C, Schrot S, Zozulya A, et al. Murine brain capillary endothelial cells exhibit improved barrier properties under the influence of hydrocortisone. Brain Res 2005; 1053: 162-174.
121. Deli MA, Abraham CS, Niwa M, et al. N, N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine increases the permeability of primary mouse cerebral endothelial cell monolayers. Inflamm Res 2003; 52(Suppl 1): S39-S40.
122. Wagner EF and Risau W. Oncogenes in the study of endothelial cell growth and differentiation. Semin Cancer Biol 1994; 5: 137-145.
123. Omidi Y, Campbell L, Barar J, et al. Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies. Brain Res 2003; 990: 95-112.
124. Paolinelli R, Corada M, Ferrarini L, et al. Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro. PLoS One 2013; 8: e70233.
125. Steiner O, Coisne C, Engelhardt B, et al. Comparison of immortalized bEnd5 and primary mouse brain micro-vascular endothelial cells as in vitro blood-brain barrier models for the study of T cell extravasation. J Cereb Blood Flow Metab 2011; 31: 315-327.
126. Silwedel C and Forster C. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli. J Neuroimmunol 2006; 179: 37-45.
127. Forster C, Waschke J, Burek M, et al. Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific. J Physiol 2006; 573: 413-425.
128. Forster C, Kahles T, Kietz S, et al. Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND. J Physiol 2007; 580: 937-949.
129. Kleinschnitz C, Blecharz K, Kahles T, et al. Glucocorticoid insensitivity at the hypoxic blood-brain barrier can be reversed by inhibition of the proteasome. Stroke 2011; 42: 1081-1089.
130. Neuhaus W, Gaiser F, Mahringer A, et al. The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier. Front Cell Neurosci 2014; 8: 352.
131. Neuhaus W, Burek M, Djuzenova CS, et al. Addition of NMDA-receptor antagonist MK801 during oxygen/glucose deprivation moderately attenuates the upregulation of glucose uptake after subsequent reoxygenation in brain endothelial cells. Neurosci Lett 2012; 506: 44-49.
132. Harke N, Leers J, Kietz S, et al. Glucocorticoids regulate the human occludin gene through a single imperfect palindromic glucocorticoid response element. Mol Cell Endocrinol 2008; 295: 39-47.
133. Burek M and Forster CY. Cloning and characterization of the murine claudin-5 promoter. Mol Cell Endocrinol 2009; 298: 19-24.
134. Blecharz KG, Drenckhahn D and Forster CY. Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endo-thelial cEND cells. J Cereb Blood Flow Metab 2008; 28: 1139-1149.
135. Blecharz KG, Haghikia A, Stasiolek M, et al. Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis. Mult Scler 2010; 16: 293-302.
136. Burek M, Haghikia A, Gold R, et al. Differential cyto-kine release from brain microvascular endothelial cells treated with dexamethasone and multiple sclerosis patient sera. J Steroids Horm Sci 2014; 5: 128.
137. Abbott NJ, Hughes CC, Revest PA, et al. Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J Cell Sci 1992; 103(Pt 1): 23-37.
138. Szabo CA, Deli MA, Ngo TK, et al. Production of pure primary rat cerebral endothelial cell culture: a comparison of different methods. Neurobiology (Bp) 1997; 5: 1-16.
139. Perriere N, Demeuse P, Garcia E, et al. Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J Neurochem 2005; 93: 279-289.
140. Calabria AR, Weidenfeller C, Jones AR, et al. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. J Neurochem 2006; 97: 922-933.
141. Molino Y, Jabes F, Lacassagne E, et al. Setting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transport. J Vis Exp 2014; 88: e51278.
142. Ge S, Song L and Pachter JS. Where is the blood-brain barrier.. really? J Neurosci Res 2005; 79: 421-427.
143. Ceruti S, Colombo L, Magni G, et al. Oxygen-glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood-brain barrier. Neurochem Int 2011; 59: 259-271.
144. Lukic-Panin V, Deguchi K, Yamashita T, et al. Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage. Curr Neurovasc Res 2010; 7: 319-329.
145. Veszelka S, Toth AE, Walter FR, et al. Docosahexaenoic acid reduces amyloid-beta induced toxicity in cells of the neurovascular unit. J Alzheimers Dis 2013; 36: 487-501.
146. Hellinger E, Veszelka S, Toth AE, et al. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models. Eur J Pharm Biopharm 2012; 82: 340-351.
147. Imamura S, Tabuchi M, Kushida H, et al. The blood-brain barrier permeability of geissoschizine methyl ether in Uncaria hook, a galenical constituent of the traditional Japanese medicine yokukansan. Cell Mol Neurobiol 2011; 31: 787-793.
148. Tabuchi M, Imamura S, Kawakami Z, et al. The blood-brain barrier permeability of 18beta-glycyrrhetinic acid, a major metabolite of glycyrrhizin in Glycyrrhiza root, a constituent of the traditional Japanese medicine yoku-kansan. Cell Mol Neurobiol 2012; 32: 1139-1146.
149. Bohara M, Kambe Y, Nagayama T, et al. C-type natri-uretic peptide modulates permeability of the blood-brain barrier. J Cereb Blood Flow Metab 2014; 34: 589-596.
150. Cardoso FL, Kittel A, Veszelka S, et al. Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cells. PLoS One 2012; 7: e35919.
151. Garcia-Garcia E, Gil S, Andrieux K, et al. A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles. Cell Mol Life Sci 2005; 62: 1400-1408.
152. Horai S, Nakagawa S, Tanaka K, et al. Cilostazol strengthens barrier integrity in brain endothelial cells. Cell Mol Neurobiol 2013; 33: 291-307.
153. Takata F, Dohgu S, Yamauchi A, et al. In vitro blood-brain barrier models using brain capillary endothelial cells isolated from neonatal and adult rats retain age-related barrier properties. PLoS One 2013; 8: e55166.
154. Xue Q, Liu Y, Qi H, et al. A novel brain neurovascular unit model with neurons, astrocytes and microvascular endothelial cells of rat. Int J Biol Sci 2013; 9: 174-189.
155. Walter FR, Veszelka S, Pasztoi M, et al. Tesmilifene modifies brain endothelial functions and opens the blood-brain/blood-glioma barrier. J Neurochem 2015; 134: 1040-1054.
156. Kis B, Deli MA, Kobayashi H, et al. Adrenomedullin regulates blood-brain barrier functions in vitro. Neuroreport 2001; 12: 4139-4142.
157. Kis B, Snipes JA, Deli MA, et al. Chronic adrenome-dullin treatment improves blood-brain barrier function but has no effects on expression of tight junction proteins. Acta Neurochir Suppl 2003; 86: 565-568.
158. Warren MS, Zerangue N, Woodford K, et al. Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. Pharmacol Res 2009; 59: 404-413.
159. Calabria AR and Shusta EV. A genomic comparison of in vivo and in vitro brain microvascular endothelial cells. J Cereb Blood Flow Metab 2008; 28: 135-148.
160. Narang VS, Fraga C, Kumar N, et al. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. Am J Physiol Cell Physiol 2008; 295: C440-C450.
161. Ichikawa N, Naora K, Hirano H, et al. Isolation and primary culture of rat cerebral microvascular endothelial cells for studying drug transport in vitro. J Pharmacol Toxicol Methods 1996; 36: 45-52.
162. Pifferi F, Jouin M, Alessandri JM, et al. n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier. Prostaglandins Leukot Essent Fatty Acids 2007; 77: 279-286.
163. Pifferi F, Jouin M, Alessandri JM, et al. n-3 long-chain fatty acids and regulation of glucose transport in two models of rat brain endothelial cells. Neurochem Int 2010; 56: 703-710.
164. Hughes CC and Lantos PL. Uptake of leucine and ala-nine by cultured cerebral capillary endothelial cells. Brain Res 1989; 480: 126-132.
165. Demeuse P, Kerkhofs A, Struys-Ponsar C, et al. Compartmentalized coculture of rat brain endothelial cells and astrocytes: a syngenic model to study the blood-brain barrier. J Neurosci Methods 2002; 121: 21-31.
166. Garberg P, Ball M, Borg N, et al. In vitro models for the blood-brain barrier. Toxicol In Vitro 2005; 19: 299-334.
167. Gaillard PJ, van der Sandt IC, Voorwinden LH, et al. Astrocytes increase the functional expression of P-gly-coprotein in an in vitro model of the blood-brain barrier. Pharm Res 2000; 17: 1198-1205.
168. Helms HC, Madelung R, Waagepetersen HS, et al. In vitro evidence for the brain glutamate efflux hypothesis: brain endothelial cells cocultured with astrocytes display a polarized brain-to-blood transport of glutam-ate. Glia 2012; 60: 882-893.
169. Meresse S, Dehouck MP, Delorme P, et al. Bovine brain endothelial cells express tight junctions and monoamine oxidase activity in long-term culture. J Neurochem 1989; 53: 1363-1371.
170. Rutten MJ, Hoover RL and Karnovsky MJ. Electrical resistance and macromolecular permeability of brain endothelial monolayer cultures. Brain Res 1987; 425: 301-310.
171. Descamps L, Dehouck MP, Torpier G, et al. Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. Am J Physiol 1996; 270: H1149-H1158.
172. Fenart L, Casanova A, Dehouck B, et al. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. J Pharmacol Exp Ther 1999; 291: 1017-1022.
173. Wang W, Dentler WL and Borchardt RT. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol 2001; 280: H434-H440.
174. Boveri M, Kinsner A, Berezowski V, et al. Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide. Neuroscience 2006; 137: 1193-1209.
175. Fauquette W, Amourette C, Dehouck MP, et al. Radiation-induced blood-brain barrier damages: an in vitro study. Brain Res 2012; 1433: 114-126.
176. Dehouck MP, Dehouck B, Schluep C, et al. Drug transport to the brain: comparison between in vitro and in vivo models of the blood-brain barrier. Eur J Pharmaceut Sci 1995; 3: 357-365.
177. Dehouck MP, Jolliet-Riant P, Bree F, et al. Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models. J Neurochem 1992; 58: 1790-1797.
178. Vandenhaute E, Sevin E, Hallier-Vanuxeem D, et al. Case study: adapting in vitro blood-brain barrier models for use in early-stage drug discovery. Drug Discov Today 2012; 17: 285-290.
179. Wolburg H, Neuhaus J, Kniesel U, et al. Modulation of tight junction structure in blood-brain barrier endothe-lial cells. Effects of tissue culture, second messengers and cocultured astrocytes. J Cell Sci 1994; 107(Pt 5): 1347-1357.
180. Guillot FL and Audus KL. Angiotensin peptide regulation of bovine brain microvessel endothelial cell mono-layer permeability. J Cardiovasc Pharmacol 1991; 18: 212-218.
181. Raub TJ, Kuentzel SL and Sawada GA. Permeability of bovine brain microvessel endothelial cells in vitro: barrier tightening by a factor released from astroglioma cells. Exp Cell Res 1992; 199: 330-340.
182. Deli MA, Dehouck MP, Abraham CS, et al. Penetration of small molecular weight substances through cultured bovine brain capillary endothelial cell monolayers: the early effects of cyclic adenosine 3', 5'-monophosphate. Exp Physiol 1995; 80: 675-678.
183. Deli MA, Dehouck MP, Cecchelli R, et al. Histamine induces a selective albumin permeation through the blood-brain barrier in vitro. Inflamm Res 1995; 44(Suppl 1): S56-S57.
184. Anda T, Yamashita H, Khalid H, et al. Effect of tumor necrosis factor-alpha on the permeability of bovine brain microvessel endothelial cell monolayers. Neurol Res 1997; 19: 369-376.
185. Abbruscato TJ and Davis TP. Combination of hypoxia/aglycemia compromises in vitro blood-brain barrier integrity. J Pharmacol Exp Ther 1999; 289: 668-675.
186. Mark KS and Miller DW. Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure. Life Sci 1999; 64: 1941-1953.
187. Schaddelee MP, Voorwinden HL, van Tilburg EW, et al. Functional role of adenosine receptor subtypes in the regulation of blood-brain barrier permeability: possible implications for the design of synthetic adeno-sine derivatives. Eur J Pharm Sci 2003; 19: 13-22.
188. Helms HC and Brodin B. Generation of primary cultures of bovine brain endothelial cells and setup of cocultures with rat astrocytes. Methods Mol Biol 2014; 1135: 365-382.
189. Tsuji A, Terasaki T, Takabatake Y, et al. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. Life Sci 1992; 51: 1427-1437.
190. Fenart L, Buee-Scherrer V, Descamps L, et al. Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier. Pharm Res 1998; 15: 993-1000.
191. Rose JM, Peckham SL, Scism JL, et al. Evaluation of the role of P-glycoprotein in ivermectin uptake by primary cultures of bovine brain microvessel endothelial cells. Neurochem Res 1998; 23: 203-209.
192. van der Sandt IC, Smolders R, Nabulsi L, et al. Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier. Eur J Pharm Sci 2001; 14: 81-86.
193. van der Sandt IC, Vos CM, Nabulsi L, et al. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood-brain barrier. AIDS 2001; 15: 483-91.
194. Perloff MD, von Moltke LL, Fahey JM, et al. Induction of P-glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cells. J Pharm Pharmacol 2007; 59: 947-953.
195. Huai-Yun H, Secrest DT, Mark KS, et al. Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochem Biophys Res Commun 1998; 243: 816-820.
196. Saint-Pol J, Candela P, Boucau MC, et al. Oxysterols decrease apical-to-basolateral transport of ass peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells. Brain Res 2013; 1517: 1-15.
197. Berezowski V, Landry C, Dehouck MP, et al. Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier. Brain Res 2004; 1018: 1-9.
198. Anfuso CD, Motta C, Giurdanella G, et al. Endothelial PKCalpha-MAPK/ERK-phospholipase A2 pathway activation as a response of glioma in a triple culture model. A new role for pericytes? Biochimie 2014; 99: 77-87.
199. Hakkarainen JJ, Rilla K, Suhonen M, et al. Re-evaluation of the role of P-glycoprotein in in vitro drug permeability studies with the bovine brain microvessel endothelial cells. Xenobiotica 2014; 44: 283-294.
200. Candela P, Gosselet F, Saint-Pol J, et al. Apical-to-basolateral transport of amyloid-beta peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein. J Alzheimers Dis 2010; 22: 849-859.
201. Fillebeen C, Descamps L, Dehouck MP, et al. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem 1999; 274: 7011-7017.
202. Demeule M, Regina A, Che C, et al. Identification and design of peptides as a new drug delivery system for the brain. J Pharmacol Exp Ther 2008; 324: 1064-1072.
203. Chang J, Jallouli Y, Kroubi M, et al. Characterization of endocytosis of transferrin-coated PLGA nanoparti-cles by the blood-brain barrier. Int J Pharm 2009; 379: 285-292.
204. Raub TJ and Newton CR. Recycling kinetics and trans-cytosis of transferrin in primary cultures of bovine brain microvessel endothelial cells. J Cell Physiol 1991; 149: 141-151.
205. Audus KL and Borchardt RT. Characterization of an in vitro blood-brain barrier models system for studying drug transport and metabolism. Pharmaceut Res 1986; 3: 81-87.
206. Czeredys M, Mysiorek C, Kulikova N, et al. A polarized localization of amino acid/carnitine transporter B(0,) (ATB(0,)) in the blood-brain barrier. Biochem Biophys Res Commun 2008; 376: 267-270.
207. Terasaki T, Takakuwa S, Moritani S, et al. Transport of monocarboxylic acids at the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells. J Pharmacol Exp Ther 1991; 258: 932-937.
208. Mischeck U, Meyer J and Galla HJ. Characterization of gamma-glutamyl transpeptidase activity of cultured endothelial cells from porcine brain capillaries. Cell Tissue Res 1989; 256: 221-226.
209. Franke H, Galla H and Beuckmann CT. Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro. Brain Res Brain Res Protoc 2000; 5: 248-256.
210. Schulze C, Smales C, Rubin LL, et al. Lysophosphatidic acid increases tight junction permeability in cultured brain endothelial cells. J Neurochem 1997; 68: 991-1000.
211. Cohen-Kashi-Malina K, Cooper I and Teichberg VI. Mechanisms of glutamate efflux at the blood-brain barrier: involvement of glial cells. J Cereb Blood Flow Metab 2012; 32: 177-189.
212. Skinner RA, Gibson RM, Rothwell NJ, et al. Transport of interleukin-1 across cerebromicrovascular endothelial cells. Br J Pharmacol 2009; 156: 1115-1123.
213. Thomsen LB, Burkhart A and Moos T. A triple culture model of the blood-brain barrier using porcine brain endothelial cells, astrocytes and pericytes. PLoS One 2015; 10: e0134765.
214. Kroll S, El-Gindi J, Thanabalasundaram G, et al. Control of the blood-brain barrier by glucocorticoids and the cells of the neurovascular unit. Ann N Y Acad Sci 2009; 1165: 228-239.
215. Cantrill CA, Skinner RA, Rothwell NJ, et al. An immortalised astrocyte cell line maintains the in vivo phenotype of a primary porcine in vitro blood-brain barrier model. Brain Res 2012; 1479: 17-30.
216. Smith M, Omidi Y and Gumbleton M. Primary porcine brain microvascular endothelial cells: biochemical and functional characterisation as a model for drug transport and targeting. J Drug Target 2007; 15: 253-268.
217. Zhang Y, Li CS, Ye Y, et al. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability. Drug Metab Dispos 2006; 34: 1935-1943.
218. Thanabalasundaram G, El-Gindi J, Lischper M, et al. Methods to assess pericyte-endothelial cell interactions in a coculture model. Methods Mol Biol 2011; 686: 379-399.
219. Thanabalasundaram G, Schneidewind J, Pieper C, et al. The impact of pericytes on the blood-brain barrier integrity depends critically on the pericyte differentiation stage. Int J Biochem Cell Biol 2011; 43: 1284-1293.
220. von Wedel-Parlow M, Wolte P and Galla HJ. Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro. J Neurochem 2009; 111: 111-118.
221. Zozulya A, Weidenfeller C and Galla HJ. Pericyte-endothelial cell interaction increases MMP-9 secretion at the blood-brain barrier in vitro. Brain Res 2008; 1189: 1-11.
222. Huwyler J, Drewe J, Klusemann C, et al. Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium. Br J Pharmacol 1996; 118: 1879-1885.
223. Matthes F, Wolte P, Bockenhoff A, et al. Transport of arylsulfatase A across the blood-brain barrier in vitro. J Biol Chem 2011; 286: 17487-17494.
224. Wedel-Parlow Mv and Galla H. A microscopic in vitro study of neutrophil diapedesis across the blood-brain barrier, in Microscopy: Science, Technology, Applications and Education. In: Mendez-Vilas A and Diaz J (eds) Microscopy: Science, Technology, Applications and Education. The Badajoz, Spain: Formatex, 2010, pp.1161-1167.
225. Rempe R, Cramer S, Qiao R, et al. Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties. Cell Tissue Res 2014; 355: 717-726.
226. Bornhorst J, Wehe CA, Huwel S, et al. T Impact of manganese on and transfer across blood-brain and blood-cerebrospinal fluid barrier in vitro. J Biol Chem 2012; 287: 17140-17151.
227. Cramer S, Tacke S, Bornhorst J, et al. The influence of silver nanoparticles on the blood-brain and the blood-cerebrospinal fluid barrier in vitro. J Nanomed Nanotechnol 2014; 5: 225.
228. Lemmen J, Tozakidis IE, Bele P, et al. Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood-brain barrier after CITCO activation. Brain Res 2013; 1501: 68-80.
229. Lemmen J, Tozakidis IE and Galla HJ. Pregnane X receptor upregulates ABC-transporter Abcg2 and Abcb1 at the blood-brain barrier. Brain Res 2013; 1491: 1-13.
230. Mulac D, Huwel S, Galla HJ, et al. Permeability of ergot alkaloids across the blood-brain barrier in vitro and influence on the barrier integrity. Mol Nutr Food Res 2012; 56: 475-485.
231. Wegener J, Sieber M and Galla HJ. Impedance analysis of epithelial and endothelial cell monolayers cultured on gold surfaces. J Biochem Biophys Methods 1996; 32: 151-170.
232. Benson K, Cramer S and Galla HJ. Impedance-based cell monitoring: barrier properties and beyond. Fluids Barriers CNS 2013; 10: 5.
233. Teow HM, Zhou Z, Najlah M, et al. Delivery of pacli-taxel across cellular barriers using a dendrimer-based nanocarrier. Int J Pharm 2013; 441: 701-711.
234. Mahringer A, Delzer J and Fricker G. A fluorescence-based in vitro assay for drug interactions with breast cancer resistance protein (BCRP, ABCG2). Eur J Pharm Biopharm 2009; 72: 605-613.
235. Ott M, Fricker G and Bauer B. Pregnane X receptor (PXR) regulates P-glycoprotein at the blood-brain barrier: functional similarities between pig and human PXR. J Pharmacol Exp Ther 2009; 329: 141-149.
236. Gutmann H, Torok M, Fricker G, et al. Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro. Drug Metab Dispos 1999; 27: 937-941.
237. Sauer SW, Opp S, Mahringer A, et al. Glutaric aciduria type I and methylmalonic aciduria: simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood-brain barrier and the choroid plexus. Biochim Biophys Acta 2010; 1802: 552-560.
238. van Gelder W, Huijskes-Heins MI, van Dijk JP, et al. Quantification of different transferrin receptor pools in primary cultures of porcine blood-brain barrier endo-thelial cells. J Neurochem 1995; 64: 2708-2715.
239. Qiao R, Jia Q, Huwel S, et al. Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. ACS Nano 2012; 6: 3304-3310.
240. Hulsermann U, Hoffmann MM, Massing U, et al. Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries. J Drug Target 2009; 17: 610-618.
241. Dickens D, Yusof SR, Abbott NJ, et al. A multi-system approach assessing the interaction of anticonvulsants with P-gp. PLoS One 2013; 8: e64854.
242. Urich E, Lazic SE, Molnos J, et al. Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models. PLoS One 2012; 7: e38149.
243. Cucullo L, Couraud PO, Weksler B, et al. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neuro-vascular studies. J Cereb Blood Flow Metab 2008; 28: 312-328.
244. Weksler B, Romero IA and Couraud PO. The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 2013; 10: 16.
245. Artus C, Glacial F, Ganeshamoorthy K, et al. The Wnt/planar cell polarity signaling pathway contributes to the integrity of tight junctions in brain endothelial cells. J Cereb Blood Flow Metab 2014; 34: 433-440.
246. Coureuil M, Mikaty G, Miller F, et al. Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium. Science 2009; 325: 83-87.
247. Forster C, Burek M, Romero IA, et al. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. J Physiol 2008; 586: 1937-1949.
248. Schrade A, Sade H, Couraud PO, et al. Expression and localization of claudins-3 and-12 in transformed human brain endothelium. Fluids Barriers CNS 2012; 9: 6.
249. Vu K, Weksler B, Romero I, et al. Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans. Eukaryot Cell 2009; 8: 1803-1807.
250. Schreibelt G, Kooij G, Reijerkerk A, et al. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 2007; 21: 3666-3676.
251. Tai LM, Holloway KA, Male DK, et al. Amyloid-beta-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. J Cell Mol Med 2010; 14: 1101-1112.
252. Ohtsuki S, Ikeda C, Uchida Y, et al. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model. Mol Pharm 2013; 10: 289-296.
253. Poller B, Gutmann H, Krahenbuhl S, et al. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies. J Neurochem 2008; 107: 1358-1368.
254. Carl SM, Lindley DJ, Das D, et al. ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood-brain barrier cell line, hCMEC/D3 [corrected]. Mol Pharm 2010; 7: 1057-1068.
255. Eigenmann DE, Xue G, Kim KS, et al. Comparative study of four immortalized human brain capillary endo-thelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS 2013; 10: 33.
256. Lippmann ES, Al-Ahmad A, Azarin SM, et al. A retin-oic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Sci Rep 2014; 4: 4160.
257. Griep LM, Wolbers F, de Wagenaar B, et al. BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed Microdevices 2013; 15: 145-150.
258. Gromnicova R, Davies HA, Sreekanthreddy P, et al. Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro. PLoS One 2013; 8: e81043.
259. Lopez-Ramirez MA, Male DK, Wang C, et al. Cytokine-induced changes in the gene expression profile of a human cerebral microvascular endothelial cell-line, hCMEC/D3. Fluids Barriers CNS 2013; 10: 27.
260. Dickens D, Webb SD, Antonyuk S, et al. Transport of gabapentin by LAT1 (SLC7A5). Biochem Pharmacol 2013; 85: 1672-1683.
261. Dauchy S, Miller F, Couraud PO, et al. Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem Pharmacol 2009; 77: 897-909.
262. Poller B, Drewe J, Krahenbuhl S, et al. Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cyto-kines in a model of the human blood-brain barrier. Cell Mol Neurobiol 2010; 30: 63-70.
263. Durk MR, Chan GN, Campos CR, et al. 1alpha, 25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glyco-protein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells. J Neurochem 2012; 123: 944-953.
264. Tai LM, Reddy PS, Lopez-Ramirez MA, et al. Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123. Brain Res 2009; 1292: 14-24.
265. Bernard SC, Simpson N, Join-Lambert O, et al. Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization. Nat Med 2014; 20: 725-731.
266. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blasto-cysts. Science 1998; 282: 1145-1147.
267. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
268. Takahashi K and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
269. Megard I, Garrigues A, Orlowski S, et al. A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation. Brain Res 2002; 927: 153-167.
270. Daneman R, Agalliu D, Zhou L, et al. Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angio-genesis. Proc Natl Acad Sci USA 2009; 106: 641-646.
271. Stenman JM, Rajagopal J, Carroll TJ, et al. Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 2008; 322: 1247-1250.
272. Mizee MR, Nijland PG, van der Pol SM, et al. Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis. Acta Neuropathol 2014; 128: 691-703.
273. Mizee MR, Wooldrik D, Lakeman KA, et al. Retinoic acid induces blood-brain barrier development. J Neurosci 2013; 33: 1660-1671.
274. Tiscornia G, Vivas EL and Izpisua Belmonte JC. Diseases in a dish: modeling human genetic disorders using induced pluripotent cells. Nat Med 2011; 17: 1570-1576.
275. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-1920.
276. Yu J, Hu K, Smuga-Otto K, et al. Human induced pluri-potent stem cells free of vector and transgene sequences. Science 2009; 324: 797-801.
277. Cesar-Razquin A, Snijder B, Frappier-Brinton T, et al. A call for systematic research on solute carriers. Cell 2015; 162: 478-487.
278. del Amo EM, Urtti A and Yliperttula M. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. Eur J Pharm Sci 2008; 35: 161-174.
279. Knowland D, Arac A, Sekiguchi KJ, et al. Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke. Neuron 2014; 82: 603-617.
280. Deeken JF and Loscher W. The blood-brain barrier and cancer: transporters, treatment, and trojan horses. Clin Cancer Res 2007; 13: 1663-1674.
281. Bell RD and Zlokovic BV. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009; 118: 103-113.
282. Minagar A and Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003; 9: 540-549.
283. Daneman R. The blood-brain barrier in health and disease. Ann Neurol 2012; 72: 648-672.
284. Haseloff RF, Krause E, Bigl M, et al. Differential protein expression in brain capillary endothelial cells induced by hypoxia and posthypoxic reoxygenation. Proteomics 2006; 6: 1803-1809.
285. Kondo T, Kinouchi H, Kawase M, et al. Astroglial cells inhibit the increasing permeability of brain endothelial cell monolayer following hypoxia/reoxygenation. Neurosci Lett 1996; 208: 101-104.
286. Lochhead JJ, McCaffrey G, Quigley CE, et al. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab 2010; 30: 1625-1636.
287. Yang L, Shah KK and Abbruscato TJ. An in vitro model of ischemic stroke. Methods Mol Biol 2012; 814: 451-466.
288. Liu LB, Xue YX, Liu YH, et al. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton. J Neurosci Res 2008; 86: 1153-1168.
289. Choi YP, Lee JH, Gao MQ, et al. Cancer-associated fibroblast promote transmigration through endothelial brain cells in three-dimensional in vitro models. Int J Cancer 2014; 135: 2024-2033.
290. Fazakas C, Wilhelm I, Nagyoszi P, et al. Transmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteases. PLoS One 2011; 6: e20758.
291. Lee KY, Kim YJ, Yoo H, et al. Human brain endothe-lial cell-derived COX-2 facilitates extravasation of breast cancer cells across the blood-brain barrier. Anticancer Res 2011; 31: 4307-4313.
292. Liu Y, Liu YS, Wu PF, et al. Brain microvascular endo-thelium induced-annexin A1 secretion contributes to small cell lung cancer brain metastasis. Int J Biochem Cell Biol 2015; 66: 11-19.
293. Rodriguez PL, Jiang S, Fu Y, et al. The proinflamma-tory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions. Int J Cancer 2014; 134: 1034-1044.
294. Zlokovic BV. Neurovascular pathways to neurodegen-eration in Alzheimer's disease and other disorders. Nat Rev Neurosci 2011; 12: 723-738.
295. Jeynes B and Provias J. The case for blood-brain barrier dysfunction in the pathogenesis of Alzheimer's disease. J Neurosci Res 2011; 89: 22-28.
296. Gosselet F, Saint-Pol J, Candela P, et al. Amyloid-beta peptides, Alzheimer's disease and the blood-brain barrier. Curr Alzheimer Res 2013; 10: 1015-1033.
297. Pflanzner T, Kuhlmann CR and Pietrzik CU. Blood-brain-barrier models for the investigation of transporter-and receptor-mediated amyloid-beta clearance in Alzheimer's disease. Curr Alzheimer Res 2010; 7: 578-590.
298. Mysiorek C, Culot M, Dehouck L, et al. Peroxisome-proliferator-activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier. Curr Neurovasc Res 2009; 6: 181-193.
299. Marchi N, Hallene KL, Kight KM, et al. Significance of MDR1 and multiple drug resistance in refractory human epileptic brain. BMC Med 2004; 2: 37.